PEROXITECH THERAPEUTICS
Peroxitech Therapeutics operates as a biopharmaceutical company developing PIP-2 to reverse acute lung injury (ALI) by targeting the cytokine storm cascade process.
PEROXITECH THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.peroxitech.com
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics ReCAPTCHA AJAX Libraries API Google Analytics Classic Snowplow Weebly
Similar Organizations
Highlight Therapeutics
Highlight Therapeutics is a clinical-stage biopharmaceutical company.
CHO Plus
CHO Plus develops biotechnology solutions to create therapeutic proteins for biopharmaceutical companies.
DNA Research Institute
DNA Research Institute operates as a DNA gene therapy research company
Laser Tissue Welding
Laser Tissue Welding, Inc. is a privately owned biotherapeutic company.
Medican Enterprises
Medican Enterprises operates as a bio-pharmaceutical company.
Pharmix
Pharmix develops products for pharmaceutical companies.
Wuhan Hiteck Biological Pharma
Wuhan Hiteck Biological Pharma operates as a biopharmaceutical company.
Xenon Pharmaceuticals
Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.
ZWI Therapeutics, Inc.
ZWI Therapeutics is a biotech company developing a new polymer to reduce immunogenicity and aid pharmacokinetics of protein therapeutics.
Current Advisors List
Current Employees Featured
Investors List
Xontogeny
Xontogeny investment in Seed Round - Peroxitech Therapeutics
Official Site Inspections
http://www.peroxitech.com
- Host name: pages-custom-29.weebly.com
- IP address: 199.34.228.77
- Location: San Francisco United States
- Latitude: 37.7642
- Longitude: -122.3993
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94107
More informations about "Peroxitech Therapeutics"
Peroxitech Therapeutics - Crunchbase Company Profile …
May 12, 2021 Organization. Peroxitech Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Peroxitech Therapeutics operates as a biopharmaceutical company. ...See details»
Team - MY SITE
Aron Fisher MD, Co-Founder, is professor and director of the Institute for Environmental Medicine at the University of Pennsylvania Perelman School of Medicine.Dr. Fisher is an expert in acute …See details»
Peroxitech Company Profile 2024: Valuation, Funding & Investors
Peroxitech General Information Description. Manufacturer and developer of a novel peptide drug designed to treat and prevent acute lung injury. The company's drugs reverse acute lung injury …See details»
Peroxitech - Products, Competitors, Financials, Employees, …
Peroxitech was seeded and incubated at Xontogeny in 2021 to advance the program through confirmatory preclinical efficacy studies and further optimize the CMC development. In addition …See details»
Peroxitech Company Profile - Craft
Peroxitech $25 m in total funding,. See insights on Peroxitech including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Peroxitech Therapeutics - Funding, Financials, Valuation & Investors
Peroxitech Therapeutics operates as a biopharmaceutical company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ... How …See details»
Peroxitech Therapeutics - Contacts, Employees, Board Members, …
Peroxitech Therapeutics has 1 current employee profile, CEO and Co-Founder Thomas Han. Peroxitech Therapeutics has 4 board members and advisors, including Chris Garabedian . …See details»
Peroxitech Inc. Company Profile | Philadelphia, PA | Competitors ...
Find company research, competitor information, contact details & financial data for Peroxitech Inc. of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.See details»
Peroxitech - VentureRadar
Peroxitech is a biotech start-up out of the University of Pennsylvania. Our lead program is a breakthrough treatment for acute lung injury. The most pressing indication for our lead …See details»
Company News - MY SITE
Peroxitech Awarded NIH Grant to Develop a Novel Therapeutic Approach to Expend and Improve Lung Transplant Organ Pool Philadelphia – August 30, 2022 – Peroxitech Inc., an emerging …See details»
Penn spinout Peroxitech raises $25M to advance experimental drug
Dec 13, 2022 Peroxitech, a biopharmaceutical company co-founded by Aron Fisher of the Perelman School of Medicine and Sheldon Feinstein, formerly of Penn Medicine, has closed a …See details»
Peroxitech Announces Closing of $25M Series A Financing to …
Dec 13, 2022 Peroxitech Inc. is a privately held biopharmaceutical company focused on the development and commercialization of a novel therapeutic for treatment of acute lung injury. …See details»
Penn spinout Peroxitech raises $25M to advance novel drug to …
Dec 15, 2022 Penn spinout Peroxitech raised $25M to further develop its novel drug candidate, PIP-2. The drug is being designed to protect cells from injury and enable injured cells to …See details»
Peroxitech Therapeutics Secures Seed Financing to ... - Business Wire
May 12, 2021 Contacts. Corporate Contact: Thomas Han Peroxitech LLC. [email protected]. Media Contact: Katie Gallagher LaVoie Health Science …See details»
Peroxitech Therapeutics Secures Seed Financing to Advance New …
May 12, 2021 Peroxitech Therapeutics is a biopharmaceutical company focused on treating acute lung injury (ALI) through its development of a novel peptide to target a newly-identified …See details»
June 1, 2020 - MY SITE - peroxitech.com
Jun 1, 2020 Peroxitech Awarded NIH Grant to Develop a Novel Therapeutic Compound for Acute Lung Injury Philadelphia – June 1, 2020 – Peroxitech Inc., an emerging …See details»
Peroxitech Announces Closing of $25M Series A Financing to
Dec 13, 2022 Peroxitech Inc., an emerging biopharmaceutical company developing a novel peptide for treating acute lung injury (ALI), announced the successful completion of a Series A …See details»
Peroxitech Therapeutics Secures Seed Financing to Advance New …
PHILADELPHIA, PA, MAY 12, 2021 – Peroxitech Therapeutics, Inc., a biopharmaceutical company developing PIP-2 to reverse acute lung injury (ALI) by targeting the cytokine storm …See details»
Peroxitech Therapeutics Secures Seed Financing to Advance
May 12, 2021 Peroxitech Therapeutics is a biopharmaceutical company focused on treating acute lung injury (ALI) through its development of a novel peptide to target a newly-identified …See details»